News

April 20, 2026

NOF to Present Advanced LNP Technologies at PEGS BOSTON 2026

Tokyo, Japan – April 6, 2026 – NOF CORPORATION is pleased to announce its participation in the upcoming 22nd Annual PEGS Boston, which will be held at the Omni Boston Hotel at the Seaport, Boson, MA, USA from May 11 to 15, 2026.

The company is proud to be a Corporate Sponsor for PEGS Boston 2026.

As a part of the event, NOF CORPORATION will showcase its products and services for the Drug Delivery System at Booth #717 from May 11 to 14.

In addition, Syed Reza, Scientific & Sales Consultant at NOF AMERICA CORPORATION (a subsidiary of NOF CORPORATION), will give a presentation on the following topic on May 14.

For further information regarding the event or other inquiries, please refer to the contact form.
* Please select “Life Science” for the Business division field.

Presentation Details

  • Title
    Hybrid adjuvant-LNP mRNA Vaccines Elicit Robust CD8+ T-Cells against Neoantigen Tumors and Suppress Tumor Growth
  • Date & Time
    May 14 / 10:35 a.m. – 10:50 a.m. (EDT)
  • Conference
    Next-Generation Immunotherapies
  • Speaker
    Syed Reza, Scientific & Sales Consultant at NOF AMERICA CORPORATION
  • Abstract
    Effective mRNA cancer vaccines require lipid nanoparticles (LNPs) that balance cytoplasmic mRNA delivery with immune stimulation. We present a hybrid LNP platform, LNP(OP/EC), that combines two distinct ionizable lipids: COATSOME® SS-OP, for high transfection efficiency, and COATSOME® SS-EC, containing a Vitamin E scaffold for potent adjuvant effects. This hybrid LNP demonstrated specific cellular immunity against neoantigen tumors while minimizing general inflammatory responses.

See Also:

[View in PDF]

BACK